Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. SanBio Company Limited
  6. News
  7. Sector news
    4592   JP3336750009

SANBIO COMPANY LIMITED

(4592)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
10/25European ADRs Move Lower in Monday Trading
MT
10/25Moderna Shares Higher After Interim Data for Covid-19 Vaccine in Children
DJ
10/25ZAI LAB : Says First Patient Treated in China Portion of Global Study of Odronextamab for ..
MT
10/25SANOFI : Regeneron's Second Late-Stage Inflammatory Disease Trial Meets Primary Endpoints
MT
10/25SANOFI : Regeneron's Dupixent Improves Swallowing in Late-Stage Study
MT
10/22MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..
RE
10/22PFIZER : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Eff..
MT
10/22PFIZER : Norway Stops Second Dose COVID-19 Vaccine Inoculations For Minors
MT
10/22PFIZER : BioNTech COVID-19 Vaccine Shows Nearly 91% Efficacy in Kids
MT
10/22BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target
MT
10/22PFIZER : BioNTech COVID Vaccine Reportedly Shows Nearly 91% Efficacy in Kids
MT
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
10/22SANOFI : Regeneron's Dupixent Meets Primary, Key Secondary Endpoints in Phase 3 Trial in P..
MT
10/22REGENERON, SANOFI : Dupixent Hits Main Endpoints in Prurigo Nodularis Trial
DJ
10/22SANOFI : Regeneron's Dupixent Cuts Itch in Late-Stage Skin Disease Study
MT
10/21BIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose
MT
10/21Canada, Pfizer Strike Deal on Pediatric Vaccine Doses
DJ
10/21European ADRs Move Lower in Thursday Trading
MT
10/21PFIZER : BioNTech Say Phase 3 Trial Data Showed Efficacy of Their COVID-19 Vaccine's Boost..
MT
10/21MODERNA : EU regulator verdict on Moderna COVID-19 booster shot next week
RE
10/21Gilead Sciences, Inc. Presents Long-Term Switch Data Reinforcing Biktarvy as A Treatmen..
CI
10/21PFIZER : BioNTech Report Nearly 96% Efficacy from COVID-19 Vaccine Booster Dose
MT
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -4-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -3-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -2-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a..
DJ
10/21PFIZER : BioNTech's COVID-19 Vaccine Provides Strong Protection in Adolescents from Delta ..
MT
10/21PFIZER, BIONTECH : Phase 3 Study Shows High Efficacy of Covid-19 Vaccine Booster
DJ
10/21Novartis Signs New Deal With BioNTech to Support Production of Covid-19 Vaccine
MT
10/21Novartis Expands Fill-and-Finish Deal with BioNTech for COVID-19 Jabs
MT
10/21NOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
10/20SANOFI : Regeneron Win Expanded US FDA Nod for Asthma Drug Dupixent
MT
10/20REGENERON PHARMACEUTICALS : Sanofi Say FDA Has Expanded Approval of Dupixent to Include Ch..
MT
10/20FDA Authorizes Booster Shots for Moderna, J&J Vaccines; Greenlights Mixing Brands
MT
10/20White House Unveils COVID-19 Vaccine Distribution Plan for Children Ages 5 to 11 Upon A..
MT
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/20KAROLINSKA INSTITUTET : Two COVID-19 Vaccine Doses Increase Airway Antibodies After Infect..
MT
10/19PFIZER : CDC Study Finds Pfizer, BioNTech Vaccine 93% Effective Against Severe COVID-19 in..
MT
10/19Atea plunges after COVID-19 treatment fails to help patients in study
RE
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/19GILEAD SCIENCES : to Donate 103,000 Vials of Veklury to Indonesia, Armenia
MT
10/19Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With C..
CI
10/19FDA May Soon Allow Mix-and-Match COVID-19 Booster Shots
MT
10/18BIONTECH : EMA Issues Positive Opinion For New Formulation Of BioNTech/Pfizer COVID-19 Vac..
MT
10/18VERTEX PHARMACEUTICALS : Reports 'Unprecedented' Results From Trial of VX-880 to Treat Typ..
MT
10/18MOLECULAR TEMPLATES : Vertex Terminates Collaboration
DJ
10/18GILEAD SCIENCES : Secures FDA Approval for Expanded Indication of Biktarvy for Treatment o..
MT
10/18Molecular Templates, Inc. Receives Notice from Vertex Pharmaceuticals Incorporated to T..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SANBIO COMPANY LIMITED